Mari Nordbø Gynnild
Om
Mari Nordbø Gynnild er lege i spesialisering i indremedisin og kardiologi ved Klinikk for hjertemedisin, St. Olavs Hospital, og forsker ved K.G. Jebsen Center for Cardiac Biomarkers, Institutt for klinisk medisin, Universitetet i Oslo.
Hun er utdannet lege fra NTNU (2013) og har en doktorgrad fra NTNU (2022) i samarbeid med University Medical Center Utrecht som omhandler etterlevelse for medikamentell sekundærforebygging og hvordan man kan forutsi risiko for fremtidige hjerte- og karhendelser.
Forskningen hennes omfatter risikovurdering og forebygging av hjerte- og karsykdom, kardio-onkologi og ekkokardiografi. Hun er postdoktor i den randomiserte PRADA II-studien som undersøker om hjertemedisinen sacubitril/valsartan kan forebygge hjerteskade hos brystkreftpasienter som får cellegiftbehandling. Hun er prosjektleder for prosjektet "Risk prediction for individualized cardiovascular disease prevention" (REK 590420) og samarbeider internasjonalt om å teste og forbedre modeller som forutsier risiko for hjerte- og karsykdom.
Forskning
PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial
A randomized, placebo-controlled, multicenter trial assessing if sacubitril/valsartan given concomitantly with early breast cancer treatment regimens including anthracyclines, with or without trastuzumab, may prevent cardiac dysfunction.
Risk prediction for individualized cardiovascular disease prevention
This project aims to externally validate and compare guideline-recommended cardiovascular risk prediction tools, as well as tailor models to local settings, new settings and investigate whether these models can be extended by addition of new predictors.
ARCTIC: Cardiovascular complications of immune checkpoint inhibitors: incidence, risk prediction and early markers
This project characterises cardiovascular complications of immune checkpoint inhibitor therapy in Norwegian cancer patients using national registries, the HUNT cohort, and a prospective observational study.
Publikasjoner
2026
-
Gynnild, Mari Nordbø;
Gulati, Geeta;
Mecinaj, Albulena;
Wethal, Torgeir;
Holte, Espen;
Vinje-Jakobsen, Victoria;
Larsen, Alf Inge;
Blix, Egil Støre;
Geisler, Jürgen;
Heck, Siri Lagethon.
(2026)
Baseline and early changes in cardiac biomarkers as predictors of global longitudinal strain deterioration during breast cancer therapy: a PRADAII substudy.
European Heart Journal, Supplement
Konferanseabstract
-
Gynnild, Mari Nordbø;
Mecinaj, Albulena;
Wethal, Torgeir;
Jakobsen, Even Olav;
Vinje-Jakobsen, Victoria;
Heck, Siri Lagethon;
Larsen, Stian;
Rösner, Assami;
Dalen, Havard;
Omland, Torbjørn.
(2026)
Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy.
JACC: CardioOncology
Vitenskapelig artikkel
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Deo, Salil V;
Lim, Carl-Emil;
Logothetis, Stelios Boulitsakis;
Läll, Kristi;
Oksanen, Minna;
Dalen, Håvard;
Munkhaugen, John;
Ueda, Peter.
(2026)
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.
European Heart Journal
Vitenskapelig artikkel
-
Omland, Torbjørn;
Heck, Siri Lagethon;
Holte, Espen;
Gynnild, Mari Nordbø;
Gulati, Geeta;
Wethal, Torgeir.
(2026)
Response by Omland et al to Letter Regarding Article, “Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial”.
Circulation
Vitenskapelig artikkel
-
Kaptoge, Stephen;
Keene, Spencer J;
Reitsma, Tessa;
Shi, Wen;
Lees, Jennifer S;
Lõo, Laura;
Gynnild, Mari Nordbø;
Chilala, Chimweta;
Ritchie, Scott;
Spackman, Sarah.
(2026)
Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model.
European Heart Journal
Vitenskapelig artikkel
-
Reitsma, Tessa H;
Lim, Carl-Emil;
Gynnild, Mari Nordbø;
Kaptoge, Stephen;
Lõo, Laura;
Holtrop, Joris;
Kuźma, Łukasz;
Pennells, Lisa;
Conrad, Nathalie;
Ueda, Peter.
(2026)
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model.
European Heart Journal
Vitenskapelig artikkel
-
Holtrop, Joris;
Gynnild, Mari N;
Richards, Matthew;
Lim, Carl-Emil;
Lääperi, Mitja;
Deo, Salil V;
Dalen, Håvard;
Ueda, Peter;
Rajagopalan, Sanjay;
Chlabicz, Małgorzata.
(2026)
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score.
European Journal of Preventive Cardiology (EJPC)
Vitenskapelig artikkel
2025
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven H J;
Vinje, Victoria;
Dorresteijn, Jannick A N;
Visseren, Frank L J;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2025)
External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients.
European Journal of Preventive Cardiology (EJPC)
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Vinje-Jakobsen, Victoria;
Holtrop, Joris;
Hageman, Steven H.J.;
Holte, Espen;
Gulati, Geeta;
Heck, Siri Lagethon;
Dorresteijn, Jannick A.N.;
Visseren, Frank L.J.;
Fagerli, Unn Merete.
(2025)
Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients.
JACC: Advances
Vitenskapelig artikkel
-
Hageman, Steven H J;
Kaptoge, Stephen;
Gynnild, Mari Nordbø;
Holtrop, Joris;
Pennells, Lisa;
McEvoy, J William;
Bobak, Martin;
Pająk, Andrzej;
Pikhart, Hynek;
Tamosiunas, Abdonas.
(2025)
Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention.
European Heart Journal - Quality of Care and Clinical Outcomes
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Hageman, Steven;
Holtrop, Joris;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2025)
Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease.
European Heart Journal, Supplement
Fagartikkel
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Dammen, Toril;
Dalen, Håvard;
Saltvedt, Ingvild Tina;
Ellekjær, Hanne;
Hageman, Steven H J;
Visseren, Frank L J;
McEvoy, John William;
Dorresteijn, Jannick A N.
(2025)
Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients.
European Journal of Preventive Cardiology (EJPC)
Vitenskapelig artikkel
-
Omland, Torbjørn;
Heck, Siri Lagethon;
Holte, Espen;
Mecinaj, Albulena;
Gynnild, Mari Nordbø;
Fagerland, Morten;
Vinje, Victoria;
Næs, Anne-Katrine Lislegaard;
Blix, Egil Støre;
Larsen, Alf Inge.
(2025)
Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.
Circulation
Vitenskapelig artikkel
-
Sande, Ingvild Svorkdal;
Helgheim, Kamilla Lind;
Saltvedt, Ingvild Tina;
Røsstad, Tove Garåsen;
Spigset, Olav;
Ellekjær, Hanne;
Gynnild, Mari Nordbø.
(2025)
Follow-Up in Primary Care After Ischemic Stroke - Insights From the Nor-COAST Study.
International Journal of General Medicine
Vitenskapelig artikkel
-
Fagerli, Erlend;
Ellekjær, Hanne;
Spigset, Olav;
Saltvedt, Ingvild Tina;
Gynnild, Mari Nordbø.
(2025)
Three-year adherence to secondary prevention and vascular risk control after ischemic stroke.
European Stroke Journal
Vitenskapelig artikkel
-
Hageman, Steven HJ;
Kaptoge, Steven;
Gynnild, Mari Nordbø;
Pennels, Lisa;
Pajak, Andrzej;
Pikhart, Hynek;
Mach, Francois;
Smulders, Yvo M.;
Carballo, David;
Angelantonio, Emanuele Di.
(2025)
Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts.
European Journal of Preventive Cardiology (EJPC)
Fagartikkel
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Dammen, Toril;
Dalen, Håvard;
Hageman, Steven HJ;
Visseren, Frank;
McEvoy, John William;
Dorresteijn, Jannick;
Munkhaugen, John.
(2025)
Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease.
European Journal of Preventive Cardiology (EJPC)
Fagartikkel
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Dalen, Håvard;
Dorresteijn, Jannick;
Visseren, Frank;
Holte, Espen;
Omland, Torbjørn;
Wethal, Torgeir;
Hageman, Steven HJ.
(2025)
Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors.
European Journal of Preventive Cardiology (EJPC)
Konferanseabstract
2024
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2024)
External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment.
European Heart Journal, Supplement
Konferanseabstract
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2024)
External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients.
European Heart Journal, Supplement
Konferanseabstract
-
Gynnild, Mari Nordbø.
(2024)
Kardiovaskulær risikostratifisering.
Hjerteforum
Kommentar
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Munkhaugen, John;
Dalen, Håvard;
Lim, Carl-Emil;
Ueda, Peter;
Jernberg, Thomas;
Tuñón, José;
Chlabicz, Małgorzata;
Steg, Philippe Gabriel.
(2024)
Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model.
European Heart Journal, Supplement
Konferanseabstract
2023
-
Aakerøy, Rachel;
Gynnild, Mari Nordbø;
Løfblad, Lena;
Dyrkorn, Roar;
Ellekjær, Hanne;
Lydersen, Stian;
Helland, Arne;
Spigset, Olav.
(2023)
Direct oral anticoagulant concentrations and adherence in stroke patients.
Basic & Clinical Pharmacology & Toxicology
Vitenskapelig artikkel
2022
-
Gynnild, Mari Nordbø;
Ellekjær, Hanne;
Spigset, Olav;
Røsstad, Tove;
Næss, Halvor.
(2022)
RESIDUAL CARDIOVASCULAR RISK AFTER ISCHEMIC STROKE Risk factors, medication adherence and risk-benefit considerations.
Norges teknisk-naturvitenskapelige universitet
Doktoravhandling
-
Hageman, Steven HJ;
McKay, Ailsa;
Ueda, Peter;
Gunn, Laura;
Jernberg, Tomas;
Hagström, Emil;
Bhatt, Deepak L.;
Läll, Kristi;
Steg, Philippe Gabriel;
Mägi, Reddik.
(2022)
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm.
European Heart Journal
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Hageman, Steven H. J.;
Spigset, Olav;
Lydersen, Stian;
Saltvedt, Ingvild;
Dorresteijn, Jannick AN;
Visseren, Frank L.J.;
Ellekjær, Hanne.
(2022)
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment.
Open heart
Vitenskapelig artikkel
2021
-
Gynnild, Mari Nordbø;
Hageman, Steven HJ;
Dorresteijn, Jannick AN;
Spigset, Olav;
Lydersen, Stian;
Wethal, Torgeir;
Saltvedt, Ingvild;
Visseren, Frank LJ;
Ellekjær, Hanne.
(2021)
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention.
Clinical Epidemiology
Vitenskapelig artikkel
-
Aam, Stina;
Gynnild, Mari Nordbø;
Munthe-Kaas, Ragnhild;
Saltvedt, Ingvild;
Lydersen, Stian;
Knapskog, Anne Brita;
Ihle-Hansen, Hege;
Ellekjær, Hanne;
Eldholm, Rannveig Sakshaug;
Fure, Brynjar.
(2021)
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study.
Frontiers in Neurology
Vitenskapelig artikkel
2020
-
Gynnild, Mari Nordbø;
Aakerøy, Rachel;
Spigset, Olav;
Askim, Torunn;
Beyer, Mona Kristiansen;
Ihle-Hansen, Hege;
Munthe-Kaas, Ragnhild;
Knapskog, Anne Brita;
Lydersen, Stian;
Næss, Halvor.
(2020)
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.
Journal of Internal Medicine
Vitenskapelig artikkel
2014
-
Anshushaug, Malin;
Gynnild, Mari Aas;
Kaasa, Stein;
Kvikstad, Anne;
Grønberg, Bjørn H..
(2014)
Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Acta Oncologica
Vitenskapelig artikkel
Tidsskriftspublikasjoner
-
Gynnild, Mari Nordbø;
Gulati, Geeta;
Mecinaj, Albulena;
Wethal, Torgeir;
Holte, Espen;
Vinje-Jakobsen, Victoria;
Larsen, Alf Inge;
Blix, Egil Støre;
Geisler, Jürgen;
Heck, Siri Lagethon.
(2026)
Baseline and early changes in cardiac biomarkers as predictors of global longitudinal strain deterioration during breast cancer therapy: a PRADAII substudy.
European Heart Journal, Supplement
Konferanseabstract
-
Gynnild, Mari Nordbø;
Mecinaj, Albulena;
Wethal, Torgeir;
Jakobsen, Even Olav;
Vinje-Jakobsen, Victoria;
Heck, Siri Lagethon;
Larsen, Stian;
Rösner, Assami;
Dalen, Havard;
Omland, Torbjørn.
(2026)
Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy.
JACC: CardioOncology
Vitenskapelig artikkel
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Deo, Salil V;
Lim, Carl-Emil;
Logothetis, Stelios Boulitsakis;
Läll, Kristi;
Oksanen, Minna;
Dalen, Håvard;
Munkhaugen, John;
Ueda, Peter.
(2026)
Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model.
European Heart Journal
Vitenskapelig artikkel
-
Omland, Torbjørn;
Heck, Siri Lagethon;
Holte, Espen;
Gynnild, Mari Nordbø;
Gulati, Geeta;
Wethal, Torgeir.
(2026)
Response by Omland et al to Letter Regarding Article, “Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial”.
Circulation
Vitenskapelig artikkel
-
Kaptoge, Stephen;
Keene, Spencer J;
Reitsma, Tessa;
Shi, Wen;
Lees, Jennifer S;
Lõo, Laura;
Gynnild, Mari Nordbø;
Chilala, Chimweta;
Ritchie, Scott;
Spackman, Sarah.
(2026)
Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model.
European Heart Journal
Vitenskapelig artikkel
-
Reitsma, Tessa H;
Lim, Carl-Emil;
Gynnild, Mari Nordbø;
Kaptoge, Stephen;
Lõo, Laura;
Holtrop, Joris;
Kuźma, Łukasz;
Pennells, Lisa;
Conrad, Nathalie;
Ueda, Peter.
(2026)
Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model.
European Heart Journal
Vitenskapelig artikkel
-
Holtrop, Joris;
Gynnild, Mari N;
Richards, Matthew;
Lim, Carl-Emil;
Lääperi, Mitja;
Deo, Salil V;
Dalen, Håvard;
Ueda, Peter;
Rajagopalan, Sanjay;
Chlabicz, Małgorzata.
(2026)
Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score.
European Journal of Preventive Cardiology (EJPC)
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven H J;
Vinje, Victoria;
Dorresteijn, Jannick A N;
Visseren, Frank L J;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2025)
External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients.
European Journal of Preventive Cardiology (EJPC)
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Vinje-Jakobsen, Victoria;
Holtrop, Joris;
Hageman, Steven H.J.;
Holte, Espen;
Gulati, Geeta;
Heck, Siri Lagethon;
Dorresteijn, Jannick A.N.;
Visseren, Frank L.J.;
Fagerli, Unn Merete.
(2025)
Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients.
JACC: Advances
Vitenskapelig artikkel
-
Hageman, Steven H J;
Kaptoge, Stephen;
Gynnild, Mari Nordbø;
Holtrop, Joris;
Pennells, Lisa;
McEvoy, J William;
Bobak, Martin;
Pająk, Andrzej;
Pikhart, Hynek;
Tamosiunas, Abdonas.
(2025)
Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention.
European Heart Journal - Quality of Care and Clinical Outcomes
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Hageman, Steven;
Holtrop, Joris;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2025)
Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease.
European Heart Journal, Supplement
Fagartikkel
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Dammen, Toril;
Dalen, Håvard;
Saltvedt, Ingvild Tina;
Ellekjær, Hanne;
Hageman, Steven H J;
Visseren, Frank L J;
McEvoy, John William;
Dorresteijn, Jannick A N.
(2025)
Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients.
European Journal of Preventive Cardiology (EJPC)
Vitenskapelig artikkel
-
Omland, Torbjørn;
Heck, Siri Lagethon;
Holte, Espen;
Mecinaj, Albulena;
Gynnild, Mari Nordbø;
Fagerland, Morten;
Vinje, Victoria;
Næs, Anne-Katrine Lislegaard;
Blix, Egil Støre;
Larsen, Alf Inge.
(2025)
Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial.
Circulation
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2024)
External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment.
European Heart Journal, Supplement
Konferanseabstract
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Hageman, Steven HJ;
Vinje, Victoria;
Dorresteijn, Jannick AN;
Visseren, Frank;
Holte, Espen;
Dalen, Håvard;
Wethal, Torgeir;
Omland, Torbjørn.
(2024)
External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients.
European Heart Journal, Supplement
Konferanseabstract
-
Gynnild, Mari Nordbø;
Aakerøy, Rachel;
Spigset, Olav;
Askim, Torunn;
Beyer, Mona Kristiansen;
Ihle-Hansen, Hege;
Munthe-Kaas, Ragnhild;
Knapskog, Anne Brita;
Lydersen, Stian;
Næss, Halvor.
(2020)
Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke.
Journal of Internal Medicine
Vitenskapelig artikkel
-
Sande, Ingvild Svorkdal;
Helgheim, Kamilla Lind;
Saltvedt, Ingvild Tina;
Røsstad, Tove Garåsen;
Spigset, Olav;
Ellekjær, Hanne;
Gynnild, Mari Nordbø.
(2025)
Follow-Up in Primary Care After Ischemic Stroke - Insights From the Nor-COAST Study.
International Journal of General Medicine
Vitenskapelig artikkel
-
Aakerøy, Rachel;
Gynnild, Mari Nordbø;
Løfblad, Lena;
Dyrkorn, Roar;
Ellekjær, Hanne;
Lydersen, Stian;
Helland, Arne;
Spigset, Olav.
(2023)
Direct oral anticoagulant concentrations and adherence in stroke patients.
Basic & Clinical Pharmacology & Toxicology
Vitenskapelig artikkel
-
Fagerli, Erlend;
Ellekjær, Hanne;
Spigset, Olav;
Saltvedt, Ingvild Tina;
Gynnild, Mari Nordbø.
(2025)
Three-year adherence to secondary prevention and vascular risk control after ischemic stroke.
European Stroke Journal
Vitenskapelig artikkel
-
Anshushaug, Malin;
Gynnild, Mari Aas;
Kaasa, Stein;
Kvikstad, Anne;
Grønberg, Bjørn H..
(2014)
Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Acta Oncologica
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Hageman, Steven HJ;
Dorresteijn, Jannick AN;
Spigset, Olav;
Lydersen, Stian;
Wethal, Torgeir;
Saltvedt, Ingvild;
Visseren, Frank LJ;
Ellekjær, Hanne.
(2021)
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention.
Clinical Epidemiology
Vitenskapelig artikkel
-
Hageman, Steven HJ;
Kaptoge, Steven;
Gynnild, Mari Nordbø;
Pennels, Lisa;
Pajak, Andrzej;
Pikhart, Hynek;
Mach, Francois;
Smulders, Yvo M.;
Carballo, David;
Angelantonio, Emanuele Di.
(2025)
Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts.
European Journal of Preventive Cardiology (EJPC)
Fagartikkel
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Dammen, Toril;
Dalen, Håvard;
Hageman, Steven HJ;
Visseren, Frank;
McEvoy, John William;
Dorresteijn, Jannick;
Munkhaugen, John.
(2025)
Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease.
European Journal of Preventive Cardiology (EJPC)
Fagartikkel
-
Gynnild, Mari Nordbø;
Holtrop, Joris;
Dalen, Håvard;
Dorresteijn, Jannick;
Visseren, Frank;
Holte, Espen;
Omland, Torbjørn;
Wethal, Torgeir;
Hageman, Steven HJ.
(2025)
Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors.
European Journal of Preventive Cardiology (EJPC)
Konferanseabstract
-
Gynnild, Mari Nordbø.
(2024)
Kardiovaskulær risikostratifisering.
Hjerteforum
Kommentar
-
Aam, Stina;
Gynnild, Mari Nordbø;
Munthe-Kaas, Ragnhild;
Saltvedt, Ingvild;
Lydersen, Stian;
Knapskog, Anne Brita;
Ihle-Hansen, Hege;
Ellekjær, Hanne;
Eldholm, Rannveig Sakshaug;
Fure, Brynjar.
(2021)
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study.
Frontiers in Neurology
Vitenskapelig artikkel
-
Hageman, Steven HJ;
McKay, Ailsa;
Ueda, Peter;
Gunn, Laura;
Jernberg, Tomas;
Hagström, Emil;
Bhatt, Deepak L.;
Läll, Kristi;
Steg, Philippe Gabriel;
Mägi, Reddik.
(2022)
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm.
European Heart Journal
Vitenskapelig artikkel
-
Gynnild, Mari Nordbø;
Hageman, Steven H. J.;
Spigset, Olav;
Lydersen, Stian;
Saltvedt, Ingvild;
Dorresteijn, Jannick AN;
Visseren, Frank L.J.;
Ellekjær, Hanne.
(2022)
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment.
Open heart
Vitenskapelig artikkel
-
Holtrop, Joris;
Gynnild, Mari Nordbø;
Munkhaugen, John;
Dalen, Håvard;
Lim, Carl-Emil;
Ueda, Peter;
Jernberg, Thomas;
Tuñón, José;
Chlabicz, Małgorzata;
Steg, Philippe Gabriel.
(2024)
Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model.
European Heart Journal, Supplement
Konferanseabstract
Studentoppgave eller avhandling
-
Gynnild, Mari Nordbø;
Ellekjær, Hanne;
Spigset, Olav;
Røsstad, Tove;
Næss, Halvor.
(2022)
RESIDUAL CARDIOVASCULAR RISK AFTER ISCHEMIC STROKE Risk factors, medication adherence and risk-benefit considerations.
Norges teknisk-naturvitenskapelige universitet
Doktoravhandling
Undervisning
Veiledning
Formidling
2026
-
KonferanseposterVinje-Jakobsen, Victoria; Gynnild, Mari Nordbø; Mecinaj, Albulena; Wisløff, Torbjørn; Holte, Espen; Wethal, Torgeir; Schirmer, Henrik; Blix, Egil Støre; Larsen, Alf Inge; Geisler, Jürgen. (2026) The effect of sacubitril/valsartan on functional disability and skeletal muscle injury during breast cancer therapy: insights from the PRADA II trial. ESC Congress 2026
-
KonferanseforedragGynnild, Mari Nordbø; Gulati, Geeta; Mecinaj, Albulena; Wethal, Torgeir; Holte, Espen; Vinje-Jakobsen, Victoria; Larsen, Alf Inge; Blix, Egil Støre; Geisler, Jürgen; Heck, Siri Lagethon. (2026) Baseline and early changes in cardiac biomarkers as predictors of global longitudinal strain deterioration during breast cancer therapy: a PRADAII substudy. ESC Cardio-Oncology 2026
2025
-
KonferanseforedragReitsma, Tessa; Holtrop, Joris; Gynnild, Mari Nordbø; Lim, Carl E; Pennels, Lisa; Keene, Spencer; Jernberg, Thomas; Bhatt, Deepak; Boer, R A De; Wood, Angela. (2025) Lifetime prediction of incident heart failure risk in patients with established atherosclerotic cardiovascular disease: the SMART2-HF risk score. ESC Congress Madrid 2025
-
KonferanseforedragGynnild, Mari Nordbø; Hageman, Steven; Holtrop, Joris; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2025) Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease. ESC Congress Madrid 2025
-
KonferanseforedragHageman, Steven H. J.; Kaptoge, Stephen; Gynnild, Mari Nordbø; Holtrop, Joris; Pennels, Lisa; McEvoy, John William; Bobak, Martin; Pajak, Andrzej; Pikhart, Hynek; Tamosiunas, Abdonas. (2025) Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention. ESC Preventive Cardiology 2025
-
KonferanseforedragGynnild, Mari Nordbø; Holtrop, Joris; Dorresteijn, Jannick A. N.; Visseren, F.L.J.; Dalen, Håvard; Holte, Espen; Wethal, Torgeir; Omland, Torbjørn; Hageman, Steven H. J.. (2025) Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors. ESC Preventive Cardiology 2025
-
KonferanseforedragHoltrop, Joris; Gynnild, Mari Nordbø; Dalen, Håvard; Dammen, Toril; McEvoy, John William; Hageman, Steven H. J.; Visseren, Frank; Munkhaugen, John; Dorresteijn, Jannick A. N.. (2025) Integration of guideline-recommended psychosocial risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with established cardiovascular disease. ESC Preventive Cardiology 2025
2024
-
KonferanseforedragHoltrop, Joris; Gynnild, Mari Nordbø; Ueda, Peter; Tuñón, José; Bhat, Deepak; Jernberg, Thomas; Visseren, Frank; Dorresteijn, Jannick A.N.; Hageman, Steven HJ. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. ESC Congress London
-
KonferanseforedragGynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick; Visseren, Frank; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients. ESC Congress London
-
KonferanseforedragGynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick A.N.; Visseren, Frank; Dalen, Håvard; Holte, Espen; Omland, Torbjørn; Wethal, Torgeir. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. ESC Congress London
2022
-
ForedragGynnild, Mari Nordbø. (2022) Etterlevelse av forbyggende behandling, er vi sammen gode nok?. Geriatrikongressen
-
IntervjuGynnild, Mari Nordbø. (2022) Under halvparten nådde de anbefalte målene for blodtrykk og kolesterol.
2021
-
ForedragGynnild, Mari Nordbø. (2021) Optimalisert etterlevelse for sekundærprofylaktiske legemidler. Bergenskonferansen, Norsk hjerneslagforening
2020
-
KonferanseposterGynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Ellekjær, Hanne. (2020) Adherence to secondary preventive anticoagulation and risk for subsequent stroke and death. European Stroke Organisation and World Stroke Organization (ESO-WSO 2020) Virtual Conference
2018
-
KonferanseposterGynnild, Mari Nordbø; Ellekjær, Hanne. (2018) Adherence to secondary prevention after stroke. European Stroke Organisation Conference (ESOC)